Literature DB >> 17697821

Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.

Josep Rodés-Cabau1, Alvaro Facta, Eric Larose, Robert DeLarochellière, Jean-Pierre Déry, Can Manh Nguyen, Louis Roy, Guy Proulx, Onil Gleeton, Gérald Barbeau, Bernard Noël, Jacques Rouleau, Jean-Roch Boudreault, Olivier F Bertrand.   

Abstract

The objective of this study was to evaluate the clinical and angiographic factors associated with significant saphenous vein graft (SVG) atherosclerosis progression at mid-term follow-up in a series of unselected coronary patients who had previously received a coronary artery bypass graft (CABG). A total of 123 SVGs from 86 patients who underwent cardiac catheterization twice, 15 +/- 12 months apart, were included in the study. None of the SVGs presented any > or =50% diameter stenosis (DS) lesion or underwent any intervention at baseline. All SVGs were divided into 3 segments and each SVG segment was scored from 0 to 3 depending on the presence of lesions, with percent DS ranging from 0% to 19% (score 0), 20% to 29% (score 1), 30% to 39% (score 2), and > or =40% (score 3). The SVG atherosclerotic burden score (ABS) was calculated by adding the score obtained for each of the 3 SVG segments. Significant progression was defined as > or =10% increase in lesion percent DS or > or =0.6 mm decrease in minimal lumen diameter between baseline and follow-up studies. Mean age of the study population was 66 +/- 9 years, and most of the patients were receiving statin therapy with mean low-density lipoprotein cholesterol of 85 +/- 26 mg/dl. Significant angiographic progression occurred in > or =1 SVG in 41 patients (48%). On multivariate analysis, the variables associated with SVG atherosclerosis progression were SVG ABS (odds ratio [OR], 1.52 for each increase of 1 point in SVG ABS; 95% confidence interval [CI] 1.1 to 2.29) and high-density lipoprotein (HDL) cholesterol (OR 1.38 for each decrease of 5 mg/dl in HDL cholesterol levels, 95% CI 1.09 to 1.85). Twenty-two patients (26%) had a cardiac event at follow-up related to SVG disease progression. The percent DS of the SVG segment at baseline was associated with SVG disease progression leading to a cardiac event (OR 3.67 for each increase of 5% in percent DS, 95% CI 2.11 to 6.38). In conclusion, simple clinical and angiographic variables such as HDL cholesterol, ABS, and lesion severity remain independent predictors of significant SVG atherosclerosis progression in mild to moderately diseased SVGs despite mean low-density lipoprotein levels <90 mg/dl.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697821     DOI: 10.1016/j.amjcard.2007.03.080

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Endoscopic venous harvesting by inexperienced operators compromises venous graft remodeling.

Authors:  Soroosh Kiani; Pranjal H Desai; Nannan Thirumvalavan; Dinesh John Kurian; Mary Margaret Flynn; XiaoQing Zhao; Robert S Poston
Journal:  Ann Thorac Surg       Date:  2011-10-13       Impact factor: 4.330

2.  A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.

Authors:  Olivier F Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence Title; Vladimir Dzavik; Madhu Natarajan; Juan Angel; Nuria Batalla; Natalie Alméras; Olivier Costerousse; Robert De Larochellière; Louis Roy; Jean-Pierre Després
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

3.  Saphenous vein graft interventions.

Authors:  Emmanouil S Brilakis; Michael Lee; Julinda Mehilli; Konstantinos Marmagkiolis; Josep Rodes-Cabau; Rajesh Sachdeva; Anna Kotsia; George Christopoulos; Bavana V Rangan; Atif Mohammed; Subhash Banerjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

4.  Targeting Wnt/β-Catenin Activated Cells with Dominant-Negative N-cadherin to Reduce Neointima Formation.

Authors:  Sarah Hulin-Curtis; Helen Williams; Kerry S Wadey; Graciela B Sala-Newby; Sarah J George
Journal:  Mol Ther Methods Clin Dev       Date:  2017-05-04       Impact factor: 6.698

5.  The BYPASS-CTCA Study: the value of Computed Tomography Cardiac Angiography (CTCA) in improving patient-related outcomes in patients with previous bypass operation undergoing invasive coronary angiography: Study Protocol of a Randomised Controlled Trial.

Authors:  Anne-Marie Beirne; Krishnaraj S Rathod; Emily Castle; Mervyn Andiapen; Amy Richards; Anna Bellin; Victoria Hammond; Thomas Godec; James C Moon; Ceri Davies; Christos V Bourantas; Andrew Wragg; Amrita Ahluwalia; Francesca Pugliese; Anthony Mathur; Daniel A Jones
Journal:  Ann Transl Med       Date:  2021-09

6.  Value of Image Fusion in Coronary Angiography for the Detection of Coronary Artery Bypass Grafts.

Authors:  Julien Plessis; Karine Warin Fresse; Zachary Cahouch; Thibaut Manigold; Vincent Letocart; Laurianne Le Gloan; Béatrice Guyomarch; Patrice Guerin
Journal:  J Am Heart Assoc       Date:  2016-06-10       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.